What are the considerations for using hydrALAZINE (Hydralazine) HCl 25 MG Tablet and metoclopramide (Reglan) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Concurrent Use of Hydralazine and Metoclopramide

Hydralazine 25 mg and metoclopramide can be safely used together without significant drug-drug interactions, but careful blood pressure monitoring is essential as both medications can cause hypotension. 1

Primary Clinical Considerations

Cardiovascular Monitoring

  • Hydralazine causes direct arteriolar vasodilation with effects beginning within 10-30 minutes and lasting 2-4 hours, which can lead to significant blood pressure reduction. 2, 3
  • Metoclopramide can cause hypotension as an adverse effect, particularly when given intravenously, creating an additive risk when combined with hydralazine 1
  • Monitor blood pressure before and after administration of either medication, particularly if the patient has baseline hypotension or diastolic blood pressure below 60 mmHg 2, 3

Common Clinical Scenarios

For Migraine Management:

  • Metoclopramide 10 mg IV or orally is recommended 20-30 minutes before or with analgesics as adjunctive therapy for acute migraine 1
  • If the patient is on scheduled hydralazine for hypertension or heart failure, verify blood pressure is adequate (diastolic >60 mmHg) before administering metoclopramide 2, 3
  • The combination poses minimal interaction risk in normotensive patients, but avoid in those with systolic BP <90 mmHg 4

For Heart Failure:

  • Hydralazine (typically combined with isosorbide dinitrate) is indicated for African American patients with NYHA class III-IV heart failure with reduced ejection fraction (LVEF ≤40%) already on ACE inhibitors and beta-blockers 1
  • If metoclopramide is needed for gastroparesis or nausea in these patients, monitor for cumulative hypotensive effects 1

Specific Adverse Effects to Monitor

Hydralazine-Related:

  • Reflex tachycardia (though attenuated in heart failure patients) 5
  • Sodium and water retention 2
  • Headache and gastrointestinal complaints (common, may limit tolerability) 1
  • Drug-induced lupus-like syndrome with chronic use at higher doses 2

Metoclopramide-Related:

  • Restlessness, drowsiness, and muscle weakness 1
  • Dystonic reactions and extrapyramidal symptoms (akathisia, pseudo-parkinsonism, tardive dyskinesia) - these are not exacerbated by hydralazine but require immediate recognition 1
  • Diarrhea 1

Additive Effects:

  • Hypotension is the primary concern requiring vigilance - hold hydralazine if diastolic BP <60 mmHg before giving metoclopramide 2, 3
  • Dizziness and drowsiness may be additive, affecting fall risk 1, 2

Contraindications and Precautions

Absolute contraindications for metoclopramide:

  • Pheochromocytoma, seizure disorder, GI bleeding, or GI obstruction 1
  • These are independent of hydralazine use

Situations requiring dose adjustment or withholding:

  • Hold hydralazine when diastolic BP <60 mmHg regardless of metoclopramide use 2, 3
  • Use caution with IV metoclopramide in patients on hydralazine who have borderline blood pressure 1

Practical Management Algorithm

  1. Check baseline blood pressure before administering either medication
  2. If diastolic BP ≥60 mmHg and systolic BP ≥90 mmHg: Both medications can be given safely with routine monitoring 2, 3, 4
  3. If diastolic BP <60 mmHg: Hold hydralazine and reassess need for metoclopramide; consider oral route if IV planned 2, 3
  4. If systolic BP <90 mmHg: Hold both medications and evaluate for causes of hypotension 2, 4
  5. Recheck blood pressure 30-60 minutes after administration to detect cumulative hypotensive effects 2, 3

Common Pitfalls to Avoid

  • Do not assume hydralazine is needed for acute blood pressure elevation - it is not a first-line agent for hypertensive urgency and has unpredictable responses with prolonged duration 3
  • Do not overlook the indication for hydralazine - if prescribed for heart failure (especially in African American patients), it should be continued unless contraindicated by hypotension 1
  • Do not give metoclopramide with adrenergic blockers (separate contraindication unrelated to hydralazine) 1
  • Recognize that hydralazine causes reflex tachycardia which is NOT a contraindication to metoclopramide use 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hypotension with Low Diastolic Blood Pressure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hydralazine in Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Isosorbide Mononitrate Mechanism and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.